Business · 22/09/1999Updated: 10/17/2026 · 1 min read
FDA Withdraws Approval of 18 New Drug Applications and 44 Abbreviated New Drug Applications
Summary
The US Food and Drug Administration (FDA) has withdrawn approval of 18 new drug applications (NDAs) and 44 abbreviated new drug applications (ANDAs) following written notifications from the applications' holders that the corresponding drug products are no longer commercially available.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →